ASKScientia develops optical and laser‑based measurement technologies for rapid, high‑resolution characterization of aerosols, sprays, and coatings, enabling real‑time insight into plume dynamics, deposition, and dissolution. Their product suite—including the OptoSleeve, D3PA imaging platform, and NResT nasal cavity model—along with contract research services, helps pharmaceutical developers de‑risk inhaled and nasal drug product pipelines through data‑driven decision making.
Funding
Funding not disclosed
Founders
Product
Problem
Developing inhaled and nasal drug products requires detailed, real-time insight into aerosol behavior, plume dynamics, deposition, and dosage, but existing measurement tools are often slow, lack physiological relevance, and do not provide continuous monitoring throughout development and clinical phases.
Solution
ASKScientia provides a portfolio of optical and laser‑based measurement technologies that deliver rapid, high‑resolution characterization of aerosols, sprays, and coatings. Their OptoSleeve captures time‑resolved plume velocity and variability, while the D3PA platform uses optical coherence tomography to image deposition, diffusion, and dissolution in real time. The NResT system offers a realistic nasal cavity model with interchangeable components and integrated sensors for physiologically relevant testing. In addition, they deliver contract research services—including aerosol and coating analysis, chemical concentration assays, and computational fluid dynamics modelling—to support early‑stage R&D and clinical trial monitoring, enabling developers to make data‑driven decisions and de‑risk product pipelines.
Target Audience
Primary customers are pharmaceutical companies and formulation developers working on orally inhaled and nasal drug products, as well as research organizations needing detailed aerosol, spray, or coating characterization and computational modelling services.
Features
- OptoSleeve device for rapid, time‑resolved aerosol plume measurements (velocity, variability, quality benchmarking)
- D3PA imaging platform leveraging OCT for high‑resolution, real‑time analysis of deposition, diffusion, and dissolution across multiple media
- NResT realistic nasal cavity model with interchangeable parts and integrated sensors for in‑vitro inhalation studies
- Patient Dose Monitor add‑on providing real‑time inhaler dose release data linked to patient inhalation profiles
- Comprehensive measurement services covering aerosol particle size, concentration, high‑speed imaging, coating thickness, and pharmaceutical ingredient quantification (including OPT‑IR spectroscopy)
- In‑house software development and advanced data analytics to transform raw measurements into actionable insights
- Computational fluid dynamics modelling to complement experimental data and support physiologically representative experiment design